Riskpilot← Back to searchSign inGet full accessScienciox A/S
A/SActiveCVR 42424641Kroghsgade 4, kl. thWholesale of other intermediate products · NACE 4686Est. 20211 employees
Revenue 2025
DKK 378K
-45% vs 2024
EBITDA margin
-47.3%
-159% vs 2024
Equity ratio
65.4%
Financial strength
Net profit 2025
DKK -111K
-43% vs 2024
| Revenue | DKK 378K | -45% |
| EBITDA | DKK -179K | -159% |
| Net profit | DKK -111K | -43% |
| Total assets | DKK 3,9M | +45% |
| Equity | DKK 2,6M | +34% |
| Employees | 1 | — |
Legal name
Scienciox A/S
CVR number
42424641
Legal form
Aktieselskab
NACE code
4686 · Wholesale of other intermediate products
Founded
26. maj 2021
Share capital
DKK 771.685
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem eller en direktør eller af den samlede
bestyrelse.
Company purpose
Selskabets formål er at virke som forsknings- og udviklingsselskab med salg af licenser til opfindelser og produkter inden for bioplastindustrien samt anden virksomhed, som efter bestyrelsens.skøn er forbundet hermed.
Address
Kroghsgade 4, kl. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 14 | 527 | 686 | 378 |
| Staff expenses | -876 | -601 | -755 | -557 |
| EBITDA | -862 | -74 | -69 | -179 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | -862 | -74 | -69 | -179 |
| Net financials | -2 | -5 | -34 | -9 |
| Profit before tax | -864 | -79 | -103 | -188 |
| Tax | -135 | -120 | -25 | -77 |
| Net profit | -729 | 42 | -77 | -111 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1.682 | 2.076 | 2.693 | 3.906 |
| Equity | 1.186 | 1.687 | 1.904 | 2.553 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 496 | 381 | 683 | 1.055 |
| Total debt | 496 | 381 | 683 | 1.055 |
EBITDA margin
-47.3%
This company
15.8%
Market median
-399% vs market
20222025
Equity ratio
65.4%
This company
38.2%
Market median
+71% vs market
20222025
Return on equity
-4.3%
This company
18.4%
Market median
-123% vs market
20222025
Net profit margin
-29.2%
This company
8.1%
Market median
-460% vs market
20222025
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20222025
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20222025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-26 – 2022-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SK Management | Management | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Lakeside Group ApS | Company | 50.0% | 50.0% | 2021 |
Høstgaard I/S v/Peter Høstgaard-Jensen; Anni Høstgaard-Jensen | Company | 5.0% | 5.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Høstgaard I/S v/Peter Høstgaard-Jensen; Anni Høstgaard-Jensen
Scienciox A/S Board members of Scienciox A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Krogsager | Management | 0 companies |
| Peter Høstgaard-Jensen | Chairman | 0 companies |
| Claus Sehested | Board of Directors | 0 companies |
| John Paulin Hansen | Board of Directors | 0 companies |
| Ann Margaret Eskildsen | Board of Directors | 0 companies |